Ireland
--:--IST
Priya Life Science Sponsor trial record
Sponsor · clinical trials

Centre Hospitalier le Mans clinical trials

Source: ClinicalTrials.gov, U.S. National Library of Medicine and the EU Clinical Trials Information System (CTIS) — current trials in our France and EU (CTIS) registers with Centre Hospitalier le Mans as lead sponsor. Synced 12 Nov 2026
18Current trials
13Recruiting now
0Drugs in these trials
2Trial registers
At a glance

Centre Hospitalier le Mans is the lead sponsor of 18 current clinical trials in our France and EU (CTIS) registers. 13 are recruiting patients now. The most common phase is Not applicable. The most-studied condition is Chest Pain.

ClinicalTrials.gov trials by status

  • Recruiting1381%
  • Not yet open319%

Trials by phase

  • Not applicable1169%
  • Observational425%
  • Phase 216%
01

Clinical trials sponsored by Centre Hospitalier le Mans

16 on ClinicalTrials.gov
StudyPhaseStatusStartRegisters
Validation of the HAR Score for Prioritization of Patients Calling the Emergency Medical Service for Chest Pain by Emergency Call Dispatcher
NCT06859021 · ClinicalTrials.gov ↗ · Chest Pain
Observational Recruiting 2025-12 France
The Impact of the Therapeutic Virtual Reality Headset on Patient Anxiety in the Waiting Room Before Flexible Bronchoscopy in Vigil
NCT06799806 · ClinicalTrials.gov ↗ · Bronchial Fibroscopy
Not applicable Recruiting 2025-02 France
Assessment of the Psychosocial Sexual Health Competencies of Young Adults Born in France (including Those Whose Parents Were Born Abroad), and Proposal of a Sexual Health Promotion Model Adapted to the Needs Identified.
NCT06825247 · ClinicalTrials.gov ↗ · Sexual Health
Observational Recruiting 2022-06 France
Adapted Physical Activity in Patients With Lower Limb Peripheral Arterial Disease
NCT04800276 · ClinicalTrials.gov ↗ · Peripheral Arterial Disease
Not applicable Recruiting 2021-02 France
Evaluation of Patient Satisfaction and Therapeutic Impact Regarding Joint Consultation Rheumatologist/Dermatologist
NCT04800289 · ClinicalTrials.gov ↗ · Psoriatic Arthritis
Observational Recruiting 2020-07 France
Mean Arterial Pressure After Out-of-hospital Cardiac Arrest
NCT05486884 · ClinicalTrials.gov ↗ · Cardiac Arrest, Out-of-hospital Cardiac Arrest (OHCA)
Not applicable Recruiting 2024-09 France
Impact of Early Rupture of the Residual Membrane on Latency Before Labour Begins
NCT07301957 · ClinicalTrials.gov ↗ · Prelabor Rupture of Membranes
Not applicable Recruiting 2026-03 France
Protecting Kidneys Through a Low Protein Diet: A Stepwise Multiple-Choice System Approach
NCT03979534 · ClinicalTrials.gov ↗ · Chronic Kidney Diseases
Not applicable Recruiting 2019-04 France
Interest of the Virtual Reality as an Analgesic Support and in the Management the Pre-procedural Anxiety in Rheumatology
NCT05289999 · ClinicalTrials.gov ↗ · Radiculopathy
Not applicable Recruiting 2022-06 France
Weight Loss Following an Episode of Pre-eclampsia Using a Dissociated or Hypocaloric Diet in Overweight or Obese Patients
NCT06067906 · ClinicalTrials.gov ↗ · Pre-Eclampsia, Obesity
Not applicable Recruiting 2023-11 France
Impact of the Choice of Gastric Tube Placement Sites on the Incidence of Ventilator Associated Pneumonia
NCT05915663 · ClinicalTrials.gov ↗ · Intubated Patient Requiring a Gastric Tube
Not applicable Recruiting 2024-11 France
Prediction of Chronic Kidney Disease Following Pre-eclampsia: Diagnosis and Early Care
NCT05056701 · ClinicalTrials.gov ↗ · Preeclampsia
Not applicable Recruiting 2022-05 France
Halo Sign Vanishing Time After Steroids Outbreak in GCA Patients
NCT07060274 · ClinicalTrials.gov ↗ · Giant Cell Arteritis (GCA), Doppler Ultrasound
Not applicable Recruiting 2026-02 France
Prophylactic ANTicoagulation With HEparine in Critically Ill Patients With Renal Impairment
NCT07365644 · ClinicalTrials.gov ↗ · Prophylactic Anticoagulation
Observational Not yet open 2026-01 France
Effect of Implementing Prevention Measures Through Personalized Information in Emergency Departments on Adherence to Prevention Measures
NCT07714460 · ClinicalTrials.gov ↗ · Prevention
Not applicable Not yet open 2026-07 France
INCREmental DIalysis and Diet for a Better Life Experience
NCT07699627 · ClinicalTrials.gov ↗ · Incremental Haemodialysis
Phase 2 Not yet open 2026-09 France

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.

02

Centre Hospitalier le Mans in the EU trials register (CTIS)

2 trials

Authorised or ongoing trials in the EU Clinical Trials Information System with Centre Hospitalier le Mans as sponsor. Some are the same study as a ClinicalTrials.gov record above; the two registries share no common ID. Trials with a site in Ireland are listed first.

StudyPhaseStatusCountries
Study of the distribution of linezolid in the prostate in patients who underwent endoscopic prostate enucleation – DiProLine
2026-527015-42-00 · Male Urogenital Diseases
Phase 1 Authorised France
INCREDIBLE: INCREmental DIalysis and diet for a Better Life Experience; Clinical relevance of an “add-on” Ketosteril supplementation on incremental haemodialysis period in incident haemodialysis patients. An exploratory randomized controlled trial
2025-524093-41-00 · CTIS ↗ · Nutritional and Metabolic Diseases
Phase 2 Authorised France
03

Conditions in Centre Hospitalier le Mans trials

19 conditions
Chest Pain1Bronchial Fibroscopy1Sexual Health1Prophylactic Anticoagulation1Prevention1Peripheral Arterial Disease1Incremental Haemodialysis1Psoriatic Arthritis1Cardiac Arrest1Out-of-hospital Cardiac Arrest (OHCA)1Prelabor Rupture of Membranes1Chronic Kidney Diseases1Radiculopathy1Pre-Eclampsia1Obesity1Intubated Patient Requiring a Gastric Tube1Preeclampsia1Giant Cell Arteritis (GCA)1Doppler Ultrasound1
04

By trial register

RegisterTrialsRecruiting
Clinical trials in France1613
EU register (CTIS)2—

A trial with sites in more than one country appears in each of those registers.

05

Questions about Centre Hospitalier le Mans trials

How many clinical trials does Centre Hospitalier le Mans sponsor?

Centre Hospitalier le Mans is the lead sponsor of 16 current trials on ClinicalTrials.gov in our France register, and 2 authorised or ongoing trials in the EU register (CTIS), as of the registry sync on 12 November 2026. Completed and withdrawn studies are not counted.

Are Centre Hospitalier le Mans trials recruiting?

Yes. 13 of its 16 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.

Where does this information come from?

Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.

Approvals, shortages and trials, every Friday

One email a week with new EMA and FDA approvals, EU and US medicine shortages, how many trials are recruiting in Ireland, and the week's Irish pharma news.

Free. Unsubscribe from any email with one click. See our privacy policy.

How this page is built

Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.

This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 12 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.